FibroBiologics, Inc. (FBLG)
About FibroBiologics, Inc.
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$18.6M
- Total assets
- $9.6M
- Market cap
- $5.4M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $16.6M
- Operating income
- -$16.6M
- Income tax
- $0
- Net income
- -$18.6M
- EPS (basic)
- $-0.42
- EPS (diluted)
- $-0.42
Balance sheet
- Total assets
- $9.6M
- Current assets
- $6.3M
- Total liabilities
- $3.5M
- Current liabilities
- $1.8M
- Shareholders’ equity
- $6.2M
Cash flow
- Operating cash flow
- -$16.4M
- Investing cash flow
- -$262.0K
- Financing cash flow
- $7.6M
- Net cash flow
- -$9.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.4M
- EPS (diluted)
- $-0.42
- Shares outstanding
- 7.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 31, 2024
FibroBiologics, Inc. (FBLG) Stock Price
- Reported a net loss of $18.6M.
- Trading 95% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review FibroBiologics, Inc..
Write a review
News about FibroBiologics, Inc.
News & sentiment via Polygon.io
FibroBiologics, Inc.: frequently asked questions
Is FibroBiologics, Inc. an American company?
FibroBiologics, Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is FibroBiologics, Inc. headquartered?
FibroBiologics, Inc. is headquartered in Houston, Texas, United States.
Is FibroBiologics, Inc. publicly traded?
Yes — FibroBiologics, Inc. is a publicly traded company. Its stock trades under the ticker symbol FBLG on the NASDAQ.
What does FibroBiologics, Inc. do?
FibroBiologics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
